Meg Leahey

Meg Leahey brings three decades of distinguished pharmaceutical regulatory expertise, specializing in Chemistry, Manufacturing, and Controls (CMC) across diverse therapeutic areas. Throughout her career, she has navigated complex regulatory landscapes for an extensive portfolio including blood products, mammalian and E. coli-derived biologics, vaccines, small molecules, combination products, and biosimilars across global markets. As GRA CMC Head Product Range 1 at Sanofi, Meg is passionate about advancing the pharmaceutical industry through strategic agency collaboration, ensuring high-quality medicines remain sustainably accessible to patients worldwide. Her comprehensive regulatory experience spans multiple product modalities and international jurisdictions, positioning her as a trusted leader in this industry. Originally from Massachusetts, Meg now calls Dublin, Ireland home, where she lives with her husband and two sons, bringing both American and European regulatory perspectives to her work.